First investigation of RH gene polymorphism in patients with sickle cell disease and associated blood donors in Cameroon, Central Africa.

2024-1-29

Lipidomic analysis of differently prepared platelet concentrates in additive solution during storage.

2023-9-1

Hepatitis E infection in adults with primary immunodeficiency with or without immunoglobulin replacement therapy.

2022-11-1

Red blood cell transfusions in preterm newborns and neurodevelopmental outcomes at 2 and 5 years of age.

2022-1-1

2° Convegno Virtuale in Medicina Trasfusionale, 22-24 settembre 2021.

2021-9-17

What the COVID-19 pandemic can teach us about inclusive blood donation.

2021-9-1

31 Congreso Nacional de la Sociedad Española de Transfusión Sanguínea y Terapia Celular - SETS, 15-20 June 2021.

2021-6-14

Continuous infusion with octocog alfa during cardiac surgery for tetralogy of Fallot in a haemophilic child.

2021-5-1

The impact of donor sex and age on stored platelet metabolism and post-transfusion recovery.

2021-5-1

Spontaneous splenic rupture due to extramedullary haematopoiesis in a patient with inherited thrombocytopenia.

2021-5-1

Two-step process of cytoskeletal structural damage during long-term storage of packed red blood cells.

2021-3-1

Successful prenatal management of two foetuses affected by antibodies against GP.Mur with prenatal genotyping analysis and a literature review.

2021-3-1

Viral metagenomics in blood donations with post-donation illness reports from Brazil.

2021-3-1

Appropriate red cell transfusions are often avoidable through Patient Blood Management.

2021-3-1

Simultaneous diagnosis of severe SARS-CoV-2 infection and sickle cell disease in two infants.

2021-3-1

Blood donation among individuals of African origin in the Netherlands: how are barriers and motivators associated with intention?

2021-1-1

Phage display reloaded: on the development of reliable monoclonal antibodies for potential Rh immune globulin production.

2021-1-1

COVID Convalescent Plasma (CCP) and its compassionate use

2021-1-1

Blood type and COVID-19: a single center experience

2021-1-1

Evans syndrome and infections: a dangerous cocktail to manage with caution.

2021-1-1

Blood donation for all: inclusivity is important to the blood supply.

2021-1-1

Acute pancreatitis due to severe hypertriglyceridemia in the COVID-19 era: role of Therapeutic Plasma Exchange

2021-1-1

SARS-CoV-2 pandemic and its impact in a Portuguese Transfusion Medicine Department

2021-1-1

Aggregates in blood filter chambers used from the plasma donations of anti-D donors: evaluation for monoclonal antibody discovery using phage display.

2021-1-1

A case of Evans syndrome secondary to COVID-19.

2021-1-1

When Sickle Cell Disease is out of control: what failed?

2021-1-1

Two novel mutations p. L319V and p. L91P in ABO glycosyltransferases lead to Ael and Bel phenotypes.

2020-11-1

If not now, when? The value of the MTP in managing massive bleeding.

2020-11-1

How well does your massive transfusion protocol perform? A scoping review of quality indicators.

2020-11-1

The effect of massive transfusion protocol implementation on the survival of trauma patients: a systematic review and meta-analysis.

2020-11-1

Transfusion-transmitted cytomegalovirus: behaviour of cell-free virus during blood component processing. A study on the safety of labile blood components in Switzerland.

2020-11-1

Pathogen reduction of blood bank components: a matter of swings and roundabouts.

2020-11-1

Prevalence and clinical features of COVID-19 in Iranian patients with congenital coagulation disorders.

2020-9-29

Patients' satisfaction associated with portable coagulometers for warfarin monitoring: a cross-sectional study.

2020-9-1

Oral iron and blood donation: cui bono?

2020-9-1

Monoclonal antibody specific to the Dia blood group antigen generated by phage display technology.

2020-9-1

Optimising prophylaxis outcomes and costs in haemophilia patients switching to recombinant FVIII-Fc: a single-centre real-world experience.

2020-9-1

D-dimer corrected for thrombin and plasmin generation is a strong predictor of mortality in patients with sepsis.

2020-7-1

Peri-operative blood transfusion in elective major surgery: incidence, indications and outcome - an observational multicentre study.

2020-7-1

Blood supply and transfusion support in southern Italy: findings during the first four weeks of the SARS-CoV-2 pandemic.

2020-5-1

COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence.

2020-5-1

Haemostatic responsiveness and release of biological response modifiers following cryopreservation of platelets treated with amotosalen and ultraviolet A light.

2020-5-1

Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial.

2020-5-1

The cardiovascular risk in paediatrics: the paradigm of the obstructive sleep apnoea syndrome.

2020-5-1

A multimodal practical approach in a Transfusion Medicine Centre to face the COVID-19 outbreak.

2020-5-1

The effect of donor's characteristics on plasmapheresis products: insights for a personalised approach.

2020-5-1

On the relevance of preoperative haemoglobin optimisation within a Patient Blood Management programme for elective hip arthroplasty surgery.

2020-5-1

Use of eye drops obtained from homologous blood source in the time of COVID-19: is there cause for ophthalmological concern?

2020-5-1

In vitro evidence supporting applications of platelet derivatives in regenerative medicine.

2020-3-1

Decoding the metabolic landscape of pathophysiological stress-induced cell death in anucleate red blood cells.

2020-3-1